Elisabeth M.W. Kooi

Dr. Elisabeth M.W. Kooi

Beatrix Children's Hospital, Neonatology, University of Groningen | RUG, Groningen, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2017 in Expert Review of Neurotherapeutics
Verified
Journal Article
Open access
EKElisabeth M.W. Kooi
Elisabeth M.W. Kooi
EVElise A. Verhagen
Elise A. Verhagen
JEJan Willem J. Elting
Jan Willem J. Elting
MCMarek Czosnyka
Marek Czosnyka
TATopun Austin
Topun Austin
MAMarcel J.H. Aries
Marcel J.H. Aries
Introduction: The preterm born infant’s ability to regulate its cerebral blood flow (CBF) is crucial in preventing secondary ischemic and hemorrhagic damage in the developing brain. The relationship between arterial blood pressure (ABP) and CBF estimates, such as regional cerebral oxygenation as measured by near-infrared spectroscopy (NIRS), is an attractive option for continuous non-invasive assessment of cerebrovascular autoregulation. Areas covered: The authors performed a literature search to provide an overview of the current literature on various current clinical practices and methods to measure cerebrovascular autoregulation in the preterm infant by NIRS. The authors focused on various aspects: Characteristics of patient cohorts, surrogate measures for cerebral perfusion pressure, NIRS devices and their accompanying parameters, definitions for impaired cerebrovascular autoregulation, methods of measurements and clinical implications. Expert commentary: Autoregulation research in preterm infants has reported many methods for measuring autoregulation using different mathematical models, signal processing and data requirements. At present, it remains unclear which NIRS signals and algorithms should be used that result in the most accurate and clinically relevant assessment of cerebrovascular autoregulation. Future studies should focus on optimizing strategies for cerebrovascular autoregulation assessment in preterm infants in order to develop autoregulation-based cerebral perfusion treatment strategies.

4 August 2018 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
THTim Hundscheid
Tim Hundscheid
WOWes Onland
Wes Onland
BOBart van Overmeire
Bart van Overmeire
PDPeter Dijk
Peter Dijk
AKAnton H. L. C. van Kaam
Anton H. L. C. van Kaam
WBWillem P. de Boode
Willem P. de Boode
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (PDA) in preterm infants, especially in those born at a gestational age (GA) less than 28 weeks. No causal relationship has been proven between a (haemodynamically significant) PDA and neonatal complications related to pulmonary hyperperfusion and/or systemic hypoperfusion. Although studies show conflicting results, a common understanding is that medical or surgical treatment of a PDA does not seem to reduce the risk of major neonatal morbidities and mortality. As the PDA might have closed spontaneously, treated children are potentially exposed to iatrogenic adverse effects. A conservative approach is gaining interest worldwide, although convincing evidence to support its use is lacking.Methods: This multicentre, randomised, non-inferiority trial is conducted in neonatal intensive care units. The study population consists of preterm infants (GA < 28 weeks) with an echocardiographic-confirmed PDA with a transductal diameter > 1.5 mm. Early treatment (between 24 and 72 h postnatal age) with the cyclooxygenase inhibitor (COXi) ibuprofen (IBU) is compared with an expectative management (no intervention intended to close a PDA). The primary outcome is the composite of mortality, and/or necrotising enterocolitis (NEC) Bell stage ≥ IIa, and/or bronchopulmonary dysplasia (BPD) defined as the need for supplemental oxygen, all at a postmenstrual age (PMA) of 36 weeks. Secondary outcome parameters are short term sequelae of cardiovascular failure, comorbidity and adverse events assessed during hospitalization and long-term neurodevelopmental outcome assessed at a corrected age of 2 years. Consequences regarding health economics are evaluated by cost effectiveness analysis and budget impact analysis.Discussion: As a conservative approach is gaining interest, we investigate whether in preterm infants, born at a GA less than 28 weeks, with a PDA an expectative management is non-inferior to early treatment with IBU regarding to the composite outcome of mortality and/or NEC and/or BPD at a PMA of 36 weeks.Trial registration: This trial is registered with the Dutch Trial RegisterNTR5479(registered on 19 October 2015), the registry sponsored by the United States National Library of Medicine Clinicaltrials.govNCT02884219(registered May 2016) and the European Clinical Trials DatabaseEudraCT 2017–001376-28.

1 April 2019 in Early Human Development
Verified
Journal Article
Closed access
TSTrijntje E. Schat
Trijntje E. Schat
AZAnne G.J.F. van Zoonen
Anne G.J.F. van Zoonen
MLMichelle E. van der Laan
Michelle E. van der Laan
MMMirthe J. Mebius
Mirthe J. Mebius
ABArend F. Bos
Arend F. Bos
EKElisabeth M.W. Kooi
Elisabeth M.W. Kooi

1 September 2020 in Clinics in Perinatology
Verified
Journal Article
Open access
EKElisabeth M.W. Kooi
Elisabeth M.W. Kooi
ARAnne E. Richter
Anne E. Richter
Cerebrovascular autoregulation is the ability to maintain stable cerebral blood flow within a range of cerebral perfusion pressures. When cerebral perfusion pressure is outside the limits of effective autoregulation, the brain is subjected to hypoperfusion or hyperperfusion, which may cause vascular injury, hemorrhage, and/or hypoxic white matter injury. Infants born preterm, after fetal growth restriction, with congenital heart disease, or with hypoxic-ischemic encephalopathy are susceptible to a failure of cerebral autoregulation. Bedside assessment of cerebrovascular autoregulation would offer the opportunity to prevent brain injury. Clinicians need to know which patient populations and circumstances are associated with impaired/absent cerebral autoregulation.

24 October 2019 in Pediatric Research
Verified
Journal Article
Open access
PDF file
SKSara J. Kuik
Sara J. Kuik
WKWillemien S. Kalteren
Willemien S. Kalteren
MMMirthe J. Mebius
Mirthe J. Mebius
ABArend F Bos
Arend F Bos
JHJan B.F. Hulscher
Jan B.F. Hulscher
EKElisabeth M.W. Kooi
Elisabeth M.W. Kooi
Background Intestinal recovery after NEC is difficult to predict in individuals. We evaluated whether several biomarkers predict intestinal recovery after NEC in preterm infants. Methods We measured intestinal tissue oxygen saturation (rintSO2) and collected urinary intestinal-fatty binding protein (I-FABPu) levels 0–24 h and 24–48 h after NEC onset, and before and after the first re-feed. We assessed intestinal recovery in two ways: time to full enteral feeding (FEFt; below or equal/above group’s median) and development of post-NEC complications (recurrent NEC/post-NEC stricture). We determined whether the rintSO2, its range, and I-FABPu differed between groups. Results We included 27 preterm infants who survived NEC (Bell’s stage ≥ 2). Median FEFt was 14 [IQR: 12–23] days. Biomarkers only predicted intestinal recovery after the first re-feed. Mean rintSO2 ≥ 53% combined with mean rintSO2range ≥ 50% predicted FEFt < 14 days with OR 16.7 (CI: 2.3–122.2). The rintSO2range was smaller (33% vs. 51%, p < 0.01) and I-FABPu was higher (92.4 vs. 25.5 ng/mL, p = 0.03) in case of post-NEC stricture, but not different in case of recurrent NEC, compared with infants without complications. Conclusion The rintSO2, its range, and I-FABPu after the first re-feed after NEC predicted intestinal recovery. These biomarkers have potential value in individualizing feeding regimens after NEC.

9 July 2018 in Children
Verified
Journal Article
Open access
PDF file
AGAisling Garvey
Aisling Garvey
EKElisabeth M.W. Kooi
Elisabeth M.W. Kooi
ASAisling Smith
Aisling Smith
EDEugene Dempsey
Eugene Dempsey
Near-infrared spectroscopy (NIRS) allows for continuous, non-invasive monitoring of end-organ tissue oxygenation. The use of NIRS, cerebral NIRS (cNIRS) in particular, in neonatal care has increased significantly over the last few years. This dynamic monitoring technique provides real-time information on the cerebral and haemodynamic status of the neonate and has the potential to serve as an important adjunct to patient care with some centres routinely utilising cNIRS to aid decision-making at the bedside. cNIRS values may be influenced by many variables, including cardiac, respiratory and metabolic parameters, and therefore it is essential to understand the pathophysiology behind alterations in cNIRS values. Correct interpretation is required to direct appropriate patient-specific interventions. This article aims to assist clinicians in deciphering cNIRS values by providing an overview of potential causes of fluctuations in cNIRS values, illustrated by common clinical scenarios, with particular emphasis on the preterm infant.